For life sciences organizations, translation quality is not just about words—it is about patient safety, regulatory compliance, and clinical accuracy. As AI becomes more common in enterprise localization, companies need reliable ways to measure whether these tools truly deliver on their promises. Sesen has introduced the SesenGPT Life Sciences Translation Benchmark Program to address this need with a structured, evidence-based approach.
This benchmarking initiative gives pharmaceutical, biotechnology, medical device, and contract research organizations a practical way to compare SesenGPT-powered translation workflows against their existing processes. Instead of relying on generic claims about speed or cost, participants evaluate performance using their own clinical, regulatory, scientific, and technical content. The result is a transparent measurement of translation quality, review effort, turnaround, and total cost—helping organizations make informed decisions about AI adoption in regulated environments.
What is the SesenGPT Benchmark Program?
The SesenGPT Life Sciences Translation Benchmark Program is a controlled evaluation initiative designed specifically for regulated life sciences content. It applies defined evaluation criteria and qualified linguistic review to compare SesenGPT-enabled workflows with conventional translation processes. The program covers six performance dimensions: translation accuracy and quality, terminology and regulatory relevance, numerical and technical precision, human review and correction effort, turnaround and workflow efficiency, and total translation cost.
Also worth a look: KaleidoscopeAI Review: AI-Powered Orthodontic Marketing System and Crestmont University DBA Review: Accelerate Executive Leadership.
What sets this program apart is its focus on measurable outcomes rather than marketing claims. Sesen’s approach acknowledges that AI translation in life sciences requires more than just an initial quality check. Organizations must assess adherence to approved terminology, numerical accuracy in dosages and warnings, and the amount of human correction needed to reach an acceptable quality threshold. The benchmark is built to answer those specific questions.
What stands out
The SesenGPT Benchmark Program offers several notable strengths for organizations considering AI-assisted translation. These features make it more than a typical vendor demo:
Uses your own content and standards
Participants bring their own representative documents, language pairs, and quality requirements. This ensures the evaluation reflects real-world scenarios instead of vendor-selected samples that may not match the complexity of the organization’s actual content.
Independent and qualified review
Translation quality is assessed by qualified medical linguists using agreed criteria, with reviewers separated from translation production where practicable. This independence adds credibility to the findings and helps organizations trust the results.
Comprehensive performance dimensions
Beyond basic translation accuracy, the program evaluates terminology consistency, numerical precision, review effort, workflow efficiency, and total cost per accepted deliverable. This broad view helps identify where AI can genuinely reduce internal burden.
Non-disruptive evaluation
The benchmark is designed to be run without replacing existing language service providers or overhauling localization infrastructure. This makes it easy for teams to participate and gather data before making any long-term commitments.
Actionable findings
At the end of the evaluation, participants receive a findings summary with performance measures, quality observations, cost comparisons, and recommendations for next steps. These insights can guide decisions about which content types are suitable for AI-enabled translation.
Who it’s for
The SesenGPT Benchmark Program is geared toward pharmaceutical and biotechnology sponsors, CROs, medical device companies, digital health organizations, and global research teams that manage multilingual clinical content. It is particularly valuable for organizations that have been evaluating AI translation but need more than anecdotal evidence to move forward. The program helps them identify where AI can deliver measurable advantages—and where human expertise remains essential.
It is also useful for groups that already have established translation workflows and approved terminology, but want to reduce internal review effort and total localization costs. Because the program uses the organization’s own content and quality standards, the results can be shared with stakeholders or used to build a business case for AI adoption. The structured approach also supports organizations that need to stay compliant with regulatory expectations for content accuracy and consistency.
How the evaluation works
The program begins with agreed scope, selection of representative documents, language pairs, and quality requirements. Confidentiality and content-transfer agreements are established before any materials are exchanged. Evaluation criteria are set in advance to ensure the comparison is meaningful, accounting for content complexity, reference materials, and review requirements.
During the evaluation, qualified reviewers compare the organization’s existing workflow with the SesenGPT-enabled process, which combines life sciences-adapted AI, customer-specific terminology, approved translation memory, specialized medical linguists, and structured quality assurance. Reviewers assess each dimension according to the agreed criteria, and the program also documents any limitations in baseline data. The final step is a findings summary that includes recommendations for potential next steps and notes where additional controls may be needed.
What makes it worth considering
Sesen brings considerable domain expertise to this program. The company is built around life sciences translation, with ISO-certified quality systems and a team of native life sciences linguists. The SesenGPT infrastructure is not a standalone AI tool; it operates within controlled workflows that include approved language assets, selective AI assistance, qualified medical linguist review, and validation-driven quality checks. This design aligns with the realities of regulated content, where accountability and precision are non-negotiable.
The benchmark also addresses a common pain point in the industry: the difficulty of moving from AI hype to proven value. Instead of asking organizations to take a leap of faith, the program gives them measurable evidence. It reveals where AI-enabled translation can improve efficiency while maintaining quality, and it honestly identifies areas where human-led translation remains preferable. This balanced, evidence-first approach is rare in the localization space and should appeal to quality-conscious life sciences teams.
Verdict
The SesenGPT Life Sciences Translation Benchmark Program is a well-designed, rigorous service that fills a genuine gap in the market. It helps life sciences organizations move beyond generic AI claims and understand exactly how AI-assisted translation performs with their content, standards, and constraints. With its independent review, comprehensive metrics, and non-disruptive process, it is a smart option for any company serious about improving translation quality and controlling costs.
Frequently asked questions
It is a structured evaluation program that lets life sciences organizations compare SesenGPT-powered translation workflows with their existing translation processes using their own clinical, regulatory, scientific, and technical content.
The program supports a broad range of life sciences documentation, including clinical trial protocols, informed consent forms, regulatory submissions, medical device instructions for use, pharmaceutical labeling, pharmacovigilance materials, and digital health content.
Qualified medical linguists and reviewers evaluate translation accuracy, terminology consistency, numerical precision, and regulatory relevance against criteria agreed upon before the benchmark begins. Reviewers are kept separate from translation production where practicable.
Yes, participants can compare their current translation processes with SesenGPT-enabled workflows using agreed performance dimensions, including review effort, turnaround, and total cost per accepted deliverable.
Participants receive a findings summary covering performance measures, translation quality observations, cost and efficiency comparisons where available, and recommendations for potential next steps.
Yes, confidentiality requirements, approved content-transfer arrangements, and necessary agreements are established before any project materials are exchanged.
No, the benchmark is designed to be non-disruptive. Organizations can evaluate new translation capabilities without replacing their current language service providers or overhauling their localization infrastructure.
